Representative Alexandria Ocasio-Cortez is well-known for making headlines, and her most recent action garnering attention is her support of more studies on psychedelic drugs.
Ocasio-Cortez introduced an amendment that would promote future studies on psychedelic substances such as MDMA, psilocybin and ibogaine. The “Amendment to Division A of Rules Committee Print 117-12” proposes serious consideration to the future of psychedelic substances in the U.S. “United States researchers to study and examine the potential impacts of several Schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases,” the amendment states.
This isn’t the first time Ocasio-Cortez has tried to get Congress on board in considering the therapeutic properties of psychedelics. Two years ago, she submitted an amendment proposal to remove a provision that prevents scientists from freely conducting research on substances like psilocybin or MDMA.
ShutterstockRepresentative Ocasio-Cortez on the War on Drugs
However, the House of Representatives rejected the proposal. “I’m a strong believer in evidence-based policymaking,” Ocasio-Cortez said during a floor debate on the topic in 2019. “And wherever there is evidence of good, we have a moral obligation to pursue and explore the parameters of that good. Even if it means challenging
Bud Digest[otw_is sidebar=otw-sidebar-8]